Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @miltenyibiotec
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @miltenyibiotec
-
We'd hate to miss out on all the fun... Get you cells who can do it all
#DollyPartonChallengepic.twitter.com/ka05eSxbN8
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#SLAS2020 is in full swing! Stop by our booth #434 to discuss your bioassays or identify the products that match your workflow the best.pic.twitter.com/sbFjky7Jiu
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
California, here we come! We are ready for takeoff to San Diego to attend
#SLAS2020. Visit our booth #434 from January 27 to 29 and check out our scientific program.http://ow.ly/oRtf50xZQ52Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Don’t miss your chance to sign up for our MACSQuant® User Day at the Science Gallery in London, 25 Feb. Experts within cell analysis in immuno-oncology, cell and gene therapy, and more will join us. Register for free today! http://ow.ly/P5Cd50xTF2B pic.twitter.com/dpd5DjnWaF
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dashing through the flow,
In a gentle way,
Through the channel we go,
Fluorescing all the way,
Ohhhh jingle cells, jingle cells …
Merry Christmas to you and your cells!
pic.twitter.com/lw3uRSSDYbHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tell us, what are the biggest hurdles bringing CAR T therapies and ATMPs into clinical application. Answer 12 questions and we will take your view right to the EU regulatory authorities: http://ow.ly/lNfQ50xyuEA
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tell us, what are the biggest hurdles bringing CAR T therapies and ATMPs into clinical application. Answer 12 questions and we will take your view right to the EU regulatory authorities: http://ow.ly/lNfQ50xyuEA
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
This is how the autoMACS® Pro looks like in our lab! We are curious about yours
.
Share a quick pic in the comments to see if you have the best looking lab!
http://ow.ly/lfs950xtxfd pic.twitter.com/qS7OP9TZhf
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Want to understand nature's complexity?
#UltraMicroscope http://ow.ly/plgy50xqpQk pic.twitter.com/nUgUVXicFD
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Proud to see the MACSQuant® Tyto® Cell Sorter is helping Immatics, a clinical-stage biopharmaceutical company, with their development of immunotherapies. http://ow.ly/q0At50xl48b pic.twitter.com/0YGPOCyqDF
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
*Gobble, gobble* Be thankful for your happy cells! Wishing all of our US customers a happy
#Thanksgiving!
pic.twitter.com/q8vpaXM3Ys
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Want to analyze complex 3D micro-environments in tumors? Discover the possibilities of light sheet microscopy for immuno-oncology here: http://ow.ly/prrV50xhNFH pic.twitter.com/4I9p3FxlUR
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CAR-T cells and more: ATMP-Workshop “Future in Medicine – Innovative Cell and Gene Therapies” Novel technologies, regulatory aspects, manufacturing and reimbursement. Presentations and discussions of leading European experts. Join us in Brussels, Dec 3: http://ow.ly/XXzi50xfSu1 pic.twitter.com/XQ3EtYieLP
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Multi-parameter T cell analysis can be challenging and requires a great deal of knowledge and experience. Such experience lies at the heart of our business, and we’re happy to be able to share it with you in our upcoming webinar on Nov 26th & 28th:http://ow.ly/cTxx50xeLEF
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Scalable & automated - Learn more about our analytical assays for cell therapy. Come to the talk of Tatjana Holzer at the CAR-TCR Analytical Development Summit in Boston. More information here: https://cell-therapy-analytics.com/ pic.twitter.com/mvEg8DHrdx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Want to get more insights into the hazardous properties of genotoxic compounds and pharmaceuticals? Then check out our new application note with Toxys describing a single high-throughput genotoxic assay.http://ow.ly/1zBw50xaCzh
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Stop by booth B3 at
#ELRIG Drug Discovery 2019 in Liverpool and unlock your high-throughput potential with our automated cell isolation and analysis solutions!pic.twitter.com/qq21rEyM2i
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’ve put a spell on our happy cells! Wishing you and your cells a fang-tastic Halloween from Miltenyi Biotec.

pic.twitter.com/nNv4EKqmN2Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Only one more week till
#ELRIG Drug Discovery in Liverpool! Don’t miss our podium presentation “Automation meets cell separation: primary cells for drug discovery assays” on Tuesday, November 5, 2019, 12:00 p.m., room 3A: http://bit.ly/2q3TrmV pic.twitter.com/XYiaMJkvRt
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Attending IUIS in Beijing? Meet our immunology application and instrument experts at our booth!
#IUIS2019pic.twitter.com/xSLNEV85nM
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.